Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein
Authors:
- Emiliano PavoniEPEmiliano Pavoni
- Michela FlegoMFMichela Flego
- Maria Luisa DupuisMDMaria Luisa Dupuis
- Stefano BarcaSBStefano Barca
- Fiorella PetronzelliFPFiorella Petronzelli
- Anna Maria AnastasiAAAnna Maria Anastasi
- Valeria D'ALessioVDValeria D'ALessio
- Angela PellicciaAPAngela Pelliccia
- Paola VaccaroPVPaola Vaccaro
- Giorgia MonteriùGMGiorgia Monteriù
- Alessandro AscioneAAAlessandro Ascione
- Rita De SantisRSRita De Santis
Open Access
- 24 February 2006
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 6 (1) , 41
Abstract
Background: CEA is a tumor-associated antigen abundantly expressed on several cancer types, including those naturally refractory to chemotherapy. The selection and characterization of human anti-CEA single-chain antibody fragments (scFv) is a first step toward the construction of new anticancer monoclonal antibodies designed for optimal blood clearance and tumor penetration.Methods: The human MA39 scFv, selected for its ability to recognize a CEA epitope expressed on human colon carcinomas, was first isolated from a large semi-synthetic ETH-2 antibody phage library, panned on human purified CEA protein. Subsequently, byin vitromutagenesis of a gene encoding for the scFv MA39, a new library was established, and new scFv antibodies with improved affinity towards the CEA cognate epitope were selected and characterized.Results: The scFv MA39 antibody was affinity-maturated byin vitromutagenesis and the new scFv clone, E8, was isolated, typed for CEA family member recognition and its CEACAM1, 3 and 5 shared epitope characterized for expression in a large panel of human normal and tumor tissues and cells.Conclusion: The binding affinity of the scFv E8 is in a range for efficient,in vivo, antigen capture in tumor cells expressing a shared epitope of the CEACAM1, 3 and 5 proteins. This new immunoreagent meets all criteria for a potential anticancer compound: it is human, hence poorly or not at all immunogenic, and it binds selectively and with good affinity to the CEA epitope expressed by metastatic melanoma and colon and lung carcinomas. Furthermore, its small molecular size should provide for efficient tissue penetration, yet give rapid plasma clearance.Keywords
This publication has 37 references indexed in Scilit:
- Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Angiogenesis and Invasion of Human Urinary Bladder CancerCancer Research, 2004
- Isolation and Characterization of the Human Monoclonal Antibodies C10 in Single-Chain Fragment Variable (scFv) Format to Glucose Oxidase from Aspergillus nigerHybridoma and Hybridomics, 2004
- CEACAM1 Enhances Invasion and Migration of Melanocytic and Melanoma CellsThe American Journal of Pathology, 2004
- The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissuesSeminars in Cancer Biology, 1999
- Three, four or more: the translational stop signal at lengthMolecular Microbiology, 1996
- Randomization of genes by PCR mutagenesis.Genome Research, 1992
- Influence of codon context on UGA suppression and readthroughJournal of Molecular Biology, 1992
- The accuracy of Qbeta RNA translation. 1. Errors during the synthesis of Qbeta proteins by intact Escherichia coli cellsEuropean Journal of Biochemistry, 1984
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978
- Isolation and characterization for carcinoembryonic antigenImmunochemistry, 1972